SIGN UP
LOG IN
21 Stocks Moving in Friday's Pre-Market Session
Gainers Athersys, Inc. (NASDAQ: ATHX) rose 48.5% to $0.4755 in pre-market trading after dropping more than 12% on Thursday.
Benzinga·06/17/2022 09:51:15
Listen to the news
Gainers
- Athersys, Inc. (NASDAQ:ATHX) rose 48.5% to $0.4755 in pre-market trading after dropping more than 12% on Thursday.
- Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) rose 31.2% to $0.3701 in pre-market trading after jumping 100% on Thursday.
- Blackboxstocks Inc (NASDAQ:BLBX) rose 27.7% to $1.66 in pre-market trading. Blackboxstocks reports in Form4 Filing that Director Ray Balestri bought 71,366 shares at an average price of $1.22 per share.
- Revlon, Inc. (NYSE:REV) rose 20% to $2.34 in pre-market trading after the company filed for Chapter 11 bankruptcy.
- ObsEva SA (NASDAQ:OBSV) shares rose 13.1% to $2.07 in pre-market trading after the company said the European Commission granted marketing authorization for Yselty® (linzagolix), an oral GnRH antagonist, for the treatment of uterine fibroids.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 12.3% to $0.16 in pre-market trading. Exela Technologies recently named Lakshmi Narayanan Chandramohan to President, Bills and Payments.
- Greenidge Generation Holdings Inc. (NASDAQ:GREE) rose 11.2% to $3.47 in pre-market trading.
- Akanda Corp. (NASDAQ:AKAN) rose 8.9% to $1.34 in pre-market trading after jumping over 32% on Thursday.
- Calliditas Therapeutics AB (NASDAQ:CALT) rose 8.8% to $17.32 in pre-market trading.
- Ballard Power Systems Inc. (NASDAQ:BLDP) shares rose 8.4% to $6.33 in pre-market trading after declining more than 6% on Thursday.
- BARK, Inc. (NYSE:BARK) shares rose 6.7% to $1.43 in pre-market trading after declining 8% on Thursday.
- Arrival (NASDAQ:ARVL) rose 6.1% to $1.39 in pre-market trading after dropping 9% on Thursday.
Don’t forget to check out our premarket coverage here .
Losers
- Addex Therapeutics Ltd (NASDAQ:ADXN) shares fell 34.8% to $2.18 in pre-market trading as the company said it has terminated dipraglurant Phase 2b/3 study in patients with dyskinesia associated with Parkinson’s Disease due to slow recruitment rate.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 24.5% to $2.30 in pre-market trading after dipping 15% on Thursday.
- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) fell 12.5% to $3.41 in pre-market trading. The U.S. Food and Drug Administration (FDA) has approved Rhythm Pharmaceuticals’ supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS).
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 11% to $0.5503 in pre-market trading. Acorda Therapeutics shares jumped around 55% on Thursday after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
- Tantech Holdings Ltd (NASDAQ:TANH) shares fell 10.5% to $0.2416 in pre-market trading.
- Aeterna Zentaris Inc. (NASDAQ:AEZS) shares fell 8% to $0.1610 in pre-market trading. Aeterna Zentaris recently achieved proof-of-concept for the treatment of NMOSD with AIM biologicals program.
- SeaChange International, Inc. (NASDAQ:SEAC) fell 7.4% to $0.5648 in pre-market trading. SeaChange and Triller, recently announced they mutually agreed to terminate their proposed merger.
- Vivakor, Inc. (NASDAQ:VIVK) fell 7.1% to $2.31 in pre-market trading. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
- Aqua Metals, Inc. (NASDAQ:AQMS) shares fell 5.6% to $1.01 in pre-market trading after jumping 16% on Thursday.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.